Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Richard Pilnik to chairman

He replaces Nick Thornton in the lead role

Chiltern Richard PilnikLondon and North Carolina-based clinical research organisation Chiltern has promoted Richard Pilnik to become its new chairman, succeeding Nick Thornton.

Pilnik became a member of the board of directors in 2015 bringing considerable industry experience across Asia, Europe, Latin America and the US to the firm.

Prior to joining Chiltern, Pilnik served as executive vice president at Quintiles and president of its Commercial Solutions division from 2009 until 2014.

He also brings leadership experience from Eli Lilly, which he joined in 1983 and subsequently held a number of senior positions including president for Europe, Middle East, Africa and CIS, and group vice president and chief marketing officer.

Jim Esinhart, chief executive officer of Chiltern, said: “On behalf of Chiltern's senior executive team and staff, as well as the investors and board of directors, I look forward to continuing to work with Rich in his new position as chairman.

“I would also like to thank Nick Thornton for his exceptional contribution to Chiltern over the past 10 years.”

9th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics